JPRN-UMIN000021841
Recruiting
N/A
Clinical trial of concurrent chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in patients with locally advanced head and neck squamous cell carcinoma - Clinical trial of concurrent chemoradiotherapy with TPF regimen in patients with locally advanced HNSCC
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- ocally advanced head and neck squamous cell carcinoma
- Sponsor
- Yokohama City University hospital
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. History of the serious hypersensitivity for drugs used in this trial 2\. The needs to use phenytoin or warfarin potassium during this trial. 3\. 24\-h creatinine clearance \<65 ml/min 4\. Active infection 5\. Active digestive tract disorder 6\. Evidence of interstinal lung disease, or pulmonary fibrosis 7\. Evidence of uncontrolled diabetes mellitus 8\. Evidence of uncontrolled cardiovascular disease 9\. Severe hepatic dysfunction 10\. Severe watery diarrhea 11\. Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 12\. Physician concludes that the patient\&\#39;s participation in this trial is inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32
Completed
Phase 3
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)anal canal canerJPRN-UMIN000003237Japan Clinical Oncology Group(JCOG)71
Completed
Phase 1
Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)JPRN-jRCT2091220010Japan Clinical Oncology Group(JCOG)81
Unknown
Phase 1
Phase I/II Study of Satraplatin Plus RadiotherapyJPRN-jRCT2080221482Yakult Honsha Co.,Ltd.33
Completed
Phase 2
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70